Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human tumor rejection antigens MAGE

K Itoh1, A Hayashi, M Nakao

  • 1Department of Immunology, Kurume University School of Medicine, Fukuoka.

Journal of Biochemistry
|March 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual function after foveal translocation with 360-degree retinotomy and simultaneous torsional muscle surgery in patients with myopic neovascular maculopathy.

American journal of ophthalmology·2001
Same author

Features of IgA nephropathy in preschool children.

Clinical nephrology·2001
Same author

Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice.

Alternative medicine review : a journal of clinical therapeutic·2001
Same author

Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells.

American journal of ophthalmology·2000
Same author

Retinal changes after retinal translocation surgery with scleral imbrication in dog eyes.

Investigative ophthalmology & visual science·2000
Same author

Foveal translocation surgery and myopic subfoveal CNV membrane.

Ophthalmology·2000

Melanoma-associated antigen (MAGE) genes are expressed in many cancers and are involved in tumor rejection. Their products show promise as targets for novel cancer vaccines.

Area of Science:

  • Molecular biology
  • Immunology
  • Oncology

Background:

  • Melanoma-associated antigen (MAGE) genes encode tumor rejection antigens found on human cancer cells.
  • MAGE proteins are normal tissue antigens present in testicular cells, crucial for early spermatogenesis.

Purpose of the Study:

  • To explore the role of MAGE genes in cancer and their potential as targets for cancer vaccines.

Main Methods:

  • Characterization of MAGE gene expression at mRNA and protein levels in various human cancers.
  • Investigation of the regulatory mechanisms, including demethylation, controlling MAGE gene expression.

Main Results:

  • MAGE-1, -2, -3, -4, and -6 genes are preferentially expressed in over half of diverse human cancers.

Related Experiment Videos

  • Demethylation of MAGE genes induces antigen expression, suggesting a link to developmental regulation and methylating control.

    • Conclusions:

    • Preferential MAGE gene expression in cancer may result from genetic instability leading to loss of methylating control.
    • MAGE gene products represent promising target molecules for the development of innovative cancer vaccines.